ITLN1 and cancer: Thus, tumor-specific directional changes in circulating ITLN1 levels, local versus global changes in ITLN1, and aggregate views of overweight/obesity or metabolic status in patient groups could lead to misinterpretations of the relationship between circulating ITLN1 and cancer risk or status.